-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KbVGZzNFkzZlxAuBPeKtHjpIt8q1nQ3H14/HjdduoibvFmFIYYV6NBoja+9WxdI4 Srt3p/9/2yD4MDxWav+zPQ== 0000945769-99-000007.txt : 19990210 0000945769-99-000007.hdr.sgml : 19990210 ACCESSION NUMBER: 0000945769-99-000007 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-43074 FILM NUMBER: 99526459 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SELTZER DAVID S CENTRAL INDEX KEY: 0001054694 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O TASHLIK KREUTZER & GOLDWYN PC STREET 2: 833 NORTHERN BLVD CITY: GREAT NECK STATE: NY ZIP: 11021 MAIL ADDRESS: STREET 1: C/O TASHLIK KREUTZER & GOLDWYN PC STREET 2: 833 NORTHERN BLVD CITY: GREAT NECK STATE: NY ZIP: 11021 SC 13G/A 1 SCHEDULE 13G, AMENDMENT ----------------------------------- OMB APPROVAL ----------------------------------- OMB Number: 3235-0145 Expires: August 31, 1999 Estimated average burden hours per response...........14.90 ----------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* HI-TECH PHARMACAL CO., INC. _____________________________________________________________ (Name of Issuer) COMMON STOCK _____________________________________________________________ (Title of Class of Securities) 42840B101 _____________________________________________________________ (CUSIP Number) December 31, 1998 _____________________________________________________________ (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: _ |_| Rule 13d-1(b) |_| Rule 13d-1(c) |X| Rule 13d-1(d) - *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 pages CUSIP No. 42840B101 13G Page 2 of 7 Pages 1. Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (entities only): Bernard Seltzer 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) Not applicable 3. SEC Use Only 4. Citizenship or Place of Organization: United States 5. Sole Voting Power NUMBER OF SHARES 726,332 BENEFICIALLY 6. Shared Voting Power -0- OWNED BY EACH 7. Sole Dispositive Power REPORTING PERSON 726,332 WITH 8. Shared Dispositive Power -0- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 726,332 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 16.1% 12. Type of Reporting Person (See Instructions) IN CUSIP NO. 42840B101 13G Page 3 of 7 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 HI-TECH PHARMACAL CO., INC. (Name of Issuer) Item 1(a) --------- Name of Issuer: Hi-Tech Pharmacal Co., Inc. Item 1(b) --------- Address of Issuer' Principal Executive Offices: 369 Bayview Avenue, Amityville, New York 11701 Item 2(a) --------- Name of Person Filing: Bernard Seltzer Item 2(b) --------- Address of Principal Business Office or, if none, Residence: 369 Bayview Avenue, Amityville, New York 11701 Item 2(c) --------- Citizenship: United States Item 2(d) --------- Title of Class of Securities: Common Stock CUSIP NO. 42840B101 13G Page 4 of 7 Pages Item 2(e) --------- CUSIP Number: 42840B101 Item 3 --------- If this statement is filed pursuant to SS240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with SS240.13d-1(b)(1) (ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with SS240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with SS240.13d-1(b)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). Not applicable CUSIP NO. 42840B101 13G Page 5 of 7 Pages Item 4 --------- Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 726,332 ..................................................................... (b) Percent of Class: 16.1% ..................................................................... (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote................726,332 (ii) Shared power to vote or to direct the vote..................-0- (iii) Sole power to dispose or to direct the disposition of...726,332 (iv) Shared power to dispose or to direct the disposition of.....-0- Item 5 --------- Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6 --------- Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7 --------- Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable CUSIP NO. 42840B101 13G Page 6 of 7 Pages Item 8 --------- Identification and Classification of Members of the Group. Not applicable Item 9 --------- Notice of Dissolution of Group. Not applicable Item 10 --------- Certification. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 8, 1999 /s/Bernard Seltzer ------------------- Bernard Seltzer -----END PRIVACY-ENHANCED MESSAGE-----